Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Non-Current Deferred Revenue (2011 - 2024)

Updated

Elite Pharmaceuticals' Non-Current Deferred Revenue came in at $2,222 for fiscal Q1 2025 (quarter ended Jun 30, 2024), down 85.7% from $15,556 a year earlier and down 60.0% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Non-Current Deferred Revenue (2011 - 2024) Analysis & Trends

At the end of FY2024 (ended Mar 31, 2024), Elite Pharmaceuticals' Non-Current Deferred Revenue was $5,556, down 70.6% from FY2023.

  • Non-Current Deferred Revenue has declined in each of the last eight fiscal years, with a five-year compound annual growth rate of -52.9% (FY2019 to FY2024).
  • Going back by fiscal year, Non-Current Deferred Revenue was $18,890 in FY2023 (-41.4%), $32,226 in FY2022 (-29.3%), $45,558 in FY2021 (-22.6%) and $58,891 in FY2020 (-75.3%).
  • The fiscal Q1 2025 figure represents the lowest quarterly Non-Current Deferred Revenue in data going back to fiscal Q4 2011.
  • Year-over-year, Non-Current Deferred Revenue has declined for 33 consecutive quarters, with an average decline of 53.5% over the last eight quarters.
  • The year-over-year decline in Non-Current Deferred Revenue has ranged between 10.7% (fiscal Q3 2021) and 91.2% (fiscal Q2 2020) over the last five years.
  • Business Quant data shows ELTP's Non-Current Deferred Revenue at $5,556 (Q4 2024), $8,889 (Q3 2024) and $12,222 (Q2 2024) in the three fiscal quarters before Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 2,222.00
Mar 31, 2024 5,556.00
Dec 31, 2023 8,889.00
Sep 30, 2023 12,222.00
Jun 30, 2023 15,556.00
Mar 31, 2023 18,890.00
Dec 31, 2022 22,223.00
Sep 30, 2022 25,556.00
Jun 30, 2022 28,889.00
Mar 31, 2022 32,226.00
Dec 31, 2021 35,559.00
Sep 30, 2021 38,892.00
Jun 30, 2021 42,225.00
Mar 31, 2021 45,558.00
Dec 31, 2020 55,558.00
Sep 30, 2020 55,558.00
Jun 30, 2020 55,558.00
Mar 31, 2020 58,891.00
Dec 31, 2019 62,224.00
Sep 30, 2019 65,557.00
API Access

Elite Pharmaceuticals Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY